OM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Outset Medical's Cost of Goods Sold for the three months ended in Mar. 2024 was $20.0 Mil. Outset Medical's Average Total Inventories for the quarter that ended in Mar. 2024 was $52.5 Mil. Outset Medical's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.38.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Outset Medical's Days Inventory for the three months ended in Mar. 2024 was 240.22.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Outset Medical's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.86.
The historical data trend for Outset Medical's Inventory Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Outset Medical Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Inventory Turnover | Get a 7-Day Free Trial | 8.63 | 5.48 | 3.30 | 2.15 | 2.01 |
Outset Medical Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Inventory Turnover | Get a 7-Day Free Trial | 0.55 | 0.61 | 0.50 | 0.47 | 0.38 |
Outset Medical's Inventory Turnover for the fiscal year that ended in Dec. 2023 is calculated as
Inventory Turnover (A: Dec. 2023 ) | |||||||
= | Cost of Goods Sold | / | Average Total Inventories | ||||
= | Cost of Goods Sold (A: Dec. 2023 ) | / ( | (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) |
= | 101.376 | / ( | (51.476 | + | 49.215) | / | 2 ) |
= | 101.376 | / | 50.3455 | ||||
= | 2.01 |
Outset Medical's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as
Inventory Turnover (Q: Mar. 2024 ) | |||||||
= | Cost of Goods Sold | / | Average Total Inventories | ||||
= | Cost of Goods Sold (Q: Mar. 2024 ) | / ( | (Total Inventories (Q: Dec. 2023 ) | + | Total Inventories (Q: Mar. 2024 )) | / | count ) |
= | 19.953 | / ( | (49.215 | + | 55.839) | / | 2 ) |
= | 19.953 | / | 52.527 | ||||
= | 0.38 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Outset Medical (NAS:OM) Inventory Turnover Explanation
Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Outset Medical's Days Inventory for the three months ended in Mar. 2024 is calculated as:
Days Inventory | = | Average Total Inventories (Q: Mar. 2024 ) | / | Cost of Goods Sold (Q: Mar. 2024 ) | * | Days in Period |
= | 52.527 | / | 19.953 | * | 365 / 4 | |
= | 240.22 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Outset Medical's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories (Q: Mar. 2024 ) | / | Revenue (Q: Mar. 2024 ) |
= | 52.527 | / | 28.168 | |
= | 1.86 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.
Thank you for viewing the detailed overview of Outset Medical's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Leslie Trigg | director, officer: President & CEO | C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112 |
Marc Nash | officer: SVP, Operations and R&D | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Jean-olivier Racine | officer: Chief Technology Officer | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Nabeel Ahmed | officer: Interim CFO | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
Stacey L. Porter | officer: Chief People Officer | 3052 ORCHARD DRIVE, SAN JOSE CA 95134 |
John L. Brottem | officer: General Counsel | 3052 ORCHARD DR., SAN JOSE CA 95134 |
Steven S. Williamson | officer: Chief Commercial Officer | C/O HOLOGIC, INC., BEDFORD MA 01730 |
Martin Vazquez | officer: Chief Operating Officer | 3052 ORCHARD DR., SAN JOSE CA 95134 |
James F. Hinrichs | director | 3750 TORREY VIEW COURT, SAN DIEGO CA 92130 |
Dale E Jones | director | C/O HUGHES SUPPLY INC, 20 N ORANGE AVE, ORLANDO FL 32801 |
D Keith Grossman | director | |
Rebecca Chambers | officer: Chief Financial Officer | 3052 ORCHARD DR., SAN JOSE CA 95134 |
Catherine M. Szyman | director | C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614 |
Warburg Pincus Llc | director, 10 percent owner | 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
Warburg Pincus X, L.p. | director, 10 percent owner | C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
From GuruFocus
By PRNewswire • 11-03-2023
By PRNewswire • 07-25-2023
By Marketwired • 07-27-2023
By Marketwired • 07-24-2023
By PRNewswire • 10-12-2023
By Business Wire • 07-19-2023
By Marketwired • 10-17-2023
By Business Wire • 08-02-2023
By Business Wire • 10-12-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.